Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Study to Evaluate the Efficacy and Safety of EDP167 in Adult Patients With Mixed Dyslipidemia

NCT07799129 is registered in ClinicalTrials.gov with Eddingpharm (Zhuhai) Co., Ltd. as lead sponsor.

NCT NCT07799129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07799129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Study to Evaluate the Efficacy and Safety of EDP167 in Adult Patients With Mixed Dyslipidemia
Lead sponsor
Eddingpharm (Zhuhai) Co., Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
April 30, 2028
Enrollment
144 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mixed dyslipidemia